Brown Financial Advisors Sells 4,036 Shares of Kenvue Inc. (NYSE:KVUE)

Brown Financial Advisors trimmed its position in Kenvue Inc. (NYSE:KVUE) by 16.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 20,316 shares of the company’s stock after selling 4,036 shares during the period. Brown Financial Advisors’ holdings in Kenvue were worth $434,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of KVUE. AMF Tjanstepension AB raised its position in Kenvue by 187.3% in the third quarter. AMF Tjanstepension AB now owns 120,477 shares of the company’s stock valued at $2,787,000 after purchasing an additional 78,540 shares during the last quarter. Signaturefd LLC increased its stake in shares of Kenvue by 394.0% in the third quarter. Signaturefd LLC now owns 4,061 shares of the company’s stock valued at $94,000 after buying an additional 3,239 shares during the period. International Assets Investment Management LLC raised its holdings in Kenvue by 1,529.5% in the 3rd quarter. International Assets Investment Management LLC now owns 106,341 shares of the company’s stock valued at $2,460,000 after buying an additional 99,815 shares during the last quarter. Allworth Financial LP boosted its position in Kenvue by 5.9% during the 3rd quarter. Allworth Financial LP now owns 20,023 shares of the company’s stock worth $463,000 after buying an additional 1,113 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in Kenvue by 143.0% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 293,310 shares of the company’s stock worth $6,822,000 after acquiring an additional 172,596 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on KVUE. Piper Sandler lifted their price target on shares of Kenvue from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Monday. Deutsche Bank Aktiengesellschaft lowered Kenvue from a “buy” rating to a “hold” rating and reduced their price target for the company from $25.00 to $24.00 in a research report on Thursday, December 12th. Canaccord Genuity Group lowered their price objective on Kenvue from $27.00 to $24.00 and set a “buy” rating for the company in a research report on Friday, February 7th. Barclays cut their price objective on Kenvue from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $24.00 target price on shares of Kenvue in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $23.08.

Kenvue Stock Up 0.0 %

Kenvue stock opened at $23.33 on Tuesday. The company has a market capitalization of $44.72 billion, a PE ratio of 44.01, a PEG ratio of 2.62 and a beta of 1.45. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46. The firm’s fifty day moving average is $21.33 and its 200 day moving average is $22.21. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, meeting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, sell-side analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th will be issued a $0.205 dividend. The ex-dividend date is Wednesday, February 12th. This represents a $0.82 annualized dividend and a yield of 3.52%. Kenvue’s payout ratio is currently 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.